Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy. - Wikidata - wikimedia - TriplyDB

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

http://www.wikidata.org/entity/Q34159652

about

Epigenetic Modification of Mitochondrial DNA in the Development of Diabetic Retinopathy.Vascular Smooth Muscle Sirtuin-1 Protects Against Aortic Dissection During Angiotensin II-Induced Hypertension Diabetic retinopathy and transcriptional regulation of a small molecular weight G-Protein, Rac1 Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy The Role of DNA Methylation in the Metabolic Memory Phenomenon Associated With the Continued Progression of Diabetic Retinopathy.miR-15a/16 reduces retinal leukostasis through decreased pro-inflammatory signaling.Contribution of epigenetics in diabetic retinopathy.miR-146a Attenuates Inflammatory Pathways Mediated by TLR4/NF-κB and TNFα to Protect Primary Human Retinal Microvascular Endothelial Cells Grown in High Glucose.Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy.Epigenetic regulation of redox signaling in diabetic retinopathy: Role of Nrf2.The role and therapeutic potential of melatonin in age-related ocular diseases.The Mechanism of Diabetic Retinopathy Pathogenesis Unifying Key Lipid Regulators, Sirtuin 1 and Liver X Receptor.Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology Mitochondrial pathways to cardiac recovery: TFAM.Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.MicroRNA106a regulates matrix metalloprotease 9 in a sirtuin-1 dependent mechanism.Therapeutic targets for altering mitochondrial dysfunction associated with diabetic retinopathy.Sirt1- A Guardian of the Development of Diabetic Retinopathy.Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy.Mangiferin Protects Retinal Ganglion Cells in Ischemic Mouse Retina via SIRT1.Molecular Mechanism of Transcriptional Regulation of Matrix Metalloproteinase-9 in Diabetic Retinopathy.ATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis

P2860

Q35918468-3838D0DA-B3F7-4630-A204-EBB1B0F7AAD0 Q36141895-36B4DDBD-0E0C-4168-81BD-CAB0B4745FFB Q36995557-1F99EC3D-349F-4E0C-BA08-BD0E8C729CDB Q37280210-AE796610-DA00-4ECA-A390-3FA6B19F6462 Q37384357-54E30647-16C5-4672-AFB9-7B72003E443E Q37487988-2EB0CF20-E364-45E1-A679-2BF11CE90890 Q38508141-0B3A3D67-9163-4FBE-9679-92734F42E238 Q38784593-7727BF8E-F4FC-4397-8871-5AAD7253D5F2 Q38873909-DD99BB1B-4AB6-4AB9-B3C1-770B32227C05 Q39052777-478C389C-C8F1-430B-A9B8-676E1D8BF2B2 Q39402838-BBDBED82-5893-499E-BC76-3BB30B0E7121 Q41348534-5C2DBF4F-C55D-42F8-A765-B3943BFD83AF Q41374334-8F620CA4-39A5-4CC4-A655-9F96925A6417 Q41980044-E0F6155C-C95C-4BCC-93BF-EFC5A9E4B126 Q47122605-C69A6938-E9C8-4840-860E-E7588E986C5D Q48199462-CEA20CD8-6D0D-4AAE-AFF3-2B25F8FE480E Q50049076-E13F2A2C-2962-4507-9A3C-E59EB85700D8 Q50133670-09D6ABFA-D821-4F99-A9BC-CE8212DDBCC5 Q51016986-AEEC2C12-EB76-4892-9D5B-0A383BDD38FE Q53205630-36E8DF18-C743-4A93-8D9B-377FC4CB2ACA Q53266552-49352930-E176-4125-A1C2-7354810E5342 Q58719110-C18B3E6E-99BD-40F8-9BD8-6A18B478D6D0

P2860

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

http://www.wikidata.org/entity/Q34159652

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

@ast

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

@en

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

@nl

type

label

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

@ast

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

@en

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

@nl

prefLabel

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

@ast

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

@en

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

@nl

P1433

Q34159652-137D03FF-FACA-451D-8912-461A9C6B0DF2

P1476

Q34159652-16008F02-1EE8-4077-8AEC-94DF0E012FB5

P2093

Q34159652-0181A042-F90E-45CE-A1BD-9B3F3E74AE43

Q34159652-C7FA1EA3-B065-41DB-BF4B-9728E0B91F70

P2860

Q34159652-07C54B77-859D-4657-A732-7E84B9113371

Q34159652-0BD222EC-FECF-431C-8E0B-4FD2887E0211

Q34159652-0C17647A-9828-4740-8758-0E44CBAE4321

Q34159652-0DE3FA56-1C49-4444-8566-2B4830B1DB30

Q34159652-11B68CA1-3654-4828-9954-1EB9BD76F38B

Q34159652-2205A0E6-ABBB-41A3-80E5-1442726E90DC

Q34159652-237856E6-F55D-4A89-91EA-8C487BFD70D0

Q34159652-2CACCC65-B2B8-4098-8BB8-22D707EC8BA5

Q34159652-2E72FF77-93A8-4DFD-A932-4F0473A548A5

Q34159652-300A9E1C-D75C-4B81-9E9F-3529A81DE55F

P304

Q34159652-A0665FEA-D07C-40AA-9497-A2C3D6109EFD

P31

Q34159652-9E89934D-0419-47A7-AD15-4B9613244F19

P356

Q34159652-36B6C438-BCA8-402F-8380-F5BA311B6524

P407

Q34159652-95003A1D-0EC6-44F5-80AF-52A27919919C

P433

Q34159652-970FC320-D450-4267-8D6E-511CE4A48E19

P478

Q34159652-17E8561C-C567-47B9-A90F-E089D371086D

P50

Q34159652-726B5125-4042-4363-807C-5D7F3D1CB047

P577

Q34159652-FA10435F-F72E-4298-BCCE-D198936EFD5E

P5875

Q34159652-AF861F49-E226-4A38-96A1-0D81281295D0

P698

Q34159652-B584BE6C-52DC-44C6-B240-F61C1519A724

P932

Q34159652-13467264-1390-4775-9F01-439E53CED882

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

@en

P2093

Qing Zhong

http://www.w3.org/2001/XMLSchema#string

Renu A Kowluru

http://www.w3.org/2001/XMLSchema#string

P2860

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.

Redox regulation of SIRT1 in inflammation and cellular senescence

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier

Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation

SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress

Posttranslational modification of mitochondrial transcription factor A in impaired mitochondria biogenesis: implications in diabetic retinopathy and metabolic memory phenomenon.

How does SIRT1 affect metabolism, senescence and cancer?

Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras.

Role of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenon associated with its progression.

P304

5653-5660

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.14-14383

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262845709

http://www.w3.org/2001/XMLSchema#string

P698

24894401

http://www.w3.org/2001/XMLSchema#string

P932

4160094

http://www.w3.org/2001/XMLSchema#string